Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/52693
Title: Persistent Systemic Inflamation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype
Author: Agustí García-Navarro, Àlvar
Edwards, Lisa D.
Rennard, Stephen I.
MacNee, William
Tal-Singer, Ruth
Miller, Bruce E.
Vestbo, Jørgen
Lomas, David A.
Calverley, Peter M.
Wouters, Emiel
Crim, Courtney
Yates, Julie C.
Silverman, Edwin K.
Coxson, Harvey O.
Bakke, Per
Mayer, Ruth J.
Celli, Bartolome
Keywords: Malalties de l'aparell respiratori
Malalties pulmonars obstructives cròniques
Assaigs clínics
Respiratory diseases
Chronic obstructive pulmonary diseases
Clinical trials
Issue Date: 18-Apr-2012
Publisher: Public Library of Science (PLoS)
Abstract: BACKGROUND: Because chronic obstructive pulmonary disease (COPD) is a heterogeneous condition, the identification of specific clinical phenotypes is key to developing more effective therapies. To explore if the persistence of systemic inflammation is associated with poor clinical outcomes in COPD we assessed patients recruited to the well-characterized ECLIPSE cohort (NCT00292552). METHODS AND FINDINGS: Six inflammatory biomarkers in peripheral blood (white blood cells (WBC) count and CRP, IL-6, IL-8, fibrinogen and TNF-α levels) were quantified in 1,755 COPD patients, 297 smokers with normal spirometry and 202 non-smoker controls that were followed-up for three years. We found that, at baseline, 30% of COPD patients did not show evidence of systemic inflammation whereas 16% had persistent systemic inflammation. Even though pulmonary abnormalities were similar in these two groups, persistently inflamed patients during follow-up had significantly increased all-cause mortality (13% vs. 2%, p<0.001) and exacerbation frequency (1.5 (1.5) vs. 0.9 (1.1) per year, p<0.001) compared to non-inflamed ones. As a descriptive study our results show associations but do not prove causality. Besides this, the inflammatory response is complex and we studied only a limited panel of biomarkers, albeit they are those investigated by the majority of previous studies and are often and easily measured in clinical practice. CONCLUSIONS: Overall, these results identify a novel systemic inflammatory COPD phenotype that may be the target of specific research and treatment.
Note: Reproducció del document publicat a: http://dx.doi.org/10.1371/journal.pone.0037483
It is part of: PLoS One, 2012, vol. 7, num. 5, p. 1-10
Related resource: http://dx.doi.org/10.1371/journal.pone.0037483
URI: http://hdl.handle.net/2445/52693
ISSN: 1932-6203
Appears in Collections:Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
625706.pdf390.3 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons